What is the incidence of post-perfusion ischemia after decompression cervical surgery for severe myelomalacia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence of Post-Perfusion Ischemia After Decompression Cervical Surgery for Severe Myelomalacia

Post-perfusion ischemia (also known as "white cord syndrome") is a rare complication occurring in approximately 4-9% of patients undergoing decompression surgery for severe cervical myelomalacia. 1, 2

Pathophysiology and Mechanism

Post-perfusion ischemia after cervical decompression represents a reperfusion injury to chronically ischemic areas of the spinal cord. This occurs through the following mechanism:

  • Chronic compression causes long-standing ischemia in the spinal cord tissue
  • Sudden decompression leads to rapid restoration of blood flow
  • The reperfused tissue experiences oxidative stress and inflammatory damage
  • This results in worsening neurological symptoms despite successful surgical decompression

The radiographic hallmark is increased T2 hyperintensity in the spinal cord on post-operative MRI without other pathologic changes 1.

Risk Factors

Several factors appear to increase the risk of developing post-perfusion ischemia:

  • Severe preoperative myelomalacia on MRI
  • Advanced age (particularly over 75 years)
  • Longer duration of symptoms before treatment
  • More severe preoperative neurological dysfunction
  • Presence of abnormal EMG findings 3

Clinical Presentation

Post-perfusion ischemia typically presents as:

  • New or worsened neurological deficits immediately after an otherwise uncomplicated decompressive procedure
  • Symptoms may include hemiparesis, quadriparesis, or other focal neurological deficits
  • Symptoms occur despite radiographic evidence of adequate decompression 1

Incidence in Research

The literature shows that post-perfusion ischemia is relatively rare:

  • In the AOSpine North America CSM study, approximately 9.3% of patients exhibited postoperative functional decline
  • About 4% of patients experienced perioperative neurological complications within 20 days after surgery in otherwise uneventful surgeries 2
  • Upon literature review, "white cord syndrome" has been reported in only a handful of cases (5-7 cases documented) 1

Management of Post-Perfusion Ischemia

When post-perfusion ischemia occurs, management typically includes:

  • Maintaining mean arterial pressure (MAP) goals to ensure adequate spinal cord perfusion
  • Administration of high-dose corticosteroids
  • Intensive physical therapy and rehabilitation 1

Prognosis

Most patients with post-perfusion ischemia show improvement with appropriate management:

  • All but one patient reported in the literature improved after MAP goal maintenance, steroid administration therapy, and acute rehabilitation 1
  • However, 44% of patients undergoing decompression for cervical spondylotic myelopathy are left with substantial neurological impairment 6 months postoperatively 2

Prevention Strategies

Emerging research suggests potential preventive approaches:

  • Riluzole (an FDA-approved drug) has shown promise in animal models by attenuating oxidative DNA damage in the spinal cord and reducing postoperative decline after decompression surgery 2
  • Careful surgical technique with gradual decompression may help minimize sudden reperfusion
  • Maintaining stable blood pressure during and after surgery

Important Considerations

Despite the risk of post-perfusion ischemia, it's important to note that:

  • All patients with preoperative myelomalacia in one study had residual spinal cord abnormalities after decompression, indicating irreversible changes 4
  • However, there was no difference in clinical improvement between patients with or without myelomalacia, suggesting that decompression can still provide clinical benefit despite persistent MRI changes 4, 5
  • Surgical decompression remains the recommended treatment for moderate to severe cervical spondylotic myelopathy, with benefits maintained for 5-15 years postoperatively 3

In conclusion, while post-perfusion ischemia is a recognized complication of cervical decompression surgery for severe myelomalacia, its incidence is relatively low (4-9%). Spine surgeons should be aware of this potentially serious complication and be prepared to manage it appropriately with MAP goals, steroids, and rehabilitation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.